2014
DOI: 10.1097/sap.0b013e31828d70b3
|View full text |Cite
|
Sign up to set email alerts
|

Vasopressors and Reconstructive Flap Perfusion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(15 citation statements)
references
References 20 publications
(14 reference statements)
0
15
0
Order By: Relevance
“…The regulation of regional blood flow and overall hemodynamics including intraoperative MAP is a critical factor to maintain microvascular flap perfusion and decrease postoperative complications and morbidity ( Sigurdsson, 1995 ; Haughey et al, 2001 ; Ibrahim et al, 2014 ; Goh et al, 2019 ). Many patients undergoing head and neck reconstruction are at risk for intraoperative hypotension due to anesthetic agents, opioid analgesics, prolonged operative times, blood loss, insensible fluid loss, hypothermia, and other associated medical co-morbidities ( Sigurdsson, 1995 ; Chan et al, 2013 ; Raittinen et al, 2016 ; Goh et al, 2019 ).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The regulation of regional blood flow and overall hemodynamics including intraoperative MAP is a critical factor to maintain microvascular flap perfusion and decrease postoperative complications and morbidity ( Sigurdsson, 1995 ; Haughey et al, 2001 ; Ibrahim et al, 2014 ; Goh et al, 2019 ). Many patients undergoing head and neck reconstruction are at risk for intraoperative hypotension due to anesthetic agents, opioid analgesics, prolonged operative times, blood loss, insensible fluid loss, hypothermia, and other associated medical co-morbidities ( Sigurdsson, 1995 ; Chan et al, 2013 ; Raittinen et al, 2016 ; Goh et al, 2019 ).…”
Section: Discussionmentioning
confidence: 99%
“…Microvascular free tissue transfer (MFTT) has become an essential component of head and neck reconstruction ( Monroe et al, 2010 ). While advancements have led to excellent surgical outcomes with MFTT success rates routinely exceeding 95% ( Densky et al, 2019 ), there remains controversy regarding the use of intraoperative intravenous vasopressor agents among both surgeons and anesthesiologists during these procedures ( Harris et al, 2012 ; Chan et al, 2013 ; Ibrahim et al, 2014 ; Swanson et al, 2016 ; Wax and Azzi, 2018 ). Due to intraoperative hypotension, it is commonplace for teams to have ongoing discussions during these cases to select intraoperative fluid administration or vasopressor therapy medication and dosing.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…A 2014 systematic review of retrospective studies showed no consistent effects on flap perfusion or flap complications. 130 Subsequent to that publication, a retrospective cohort study of 682 patients and 1039 flaps also failed to demonstrate an increased risk of thrombotic events or flap loss in patients receiving vasopressors. 131 …”
Section: Evidence-based Recommendations For Components Of Eras Protocmentioning
confidence: 99%
“…It has been observed that there has been no difference in the outcomes when pressors were used or not used, and there is no reliable evidence to support contraindication of pressor use[23]. Frequency of flap necrosis and postoperative complications and adverse events were similar with or without use of intraoperative pressors[24].…”
Section: Anesthetic Considerationsmentioning
confidence: 99%